Breaking News Instant updates and real-time market news.

FB

Facebook

$188.81

(0.00%)

, V

Visa

$177.55

-1.25 (-0.70%)

13:13
10/16/19
10/16
13:13
10/16/19
13:13

Facebook exec still expects Libra to win enough financial backers, Reuters says

Facebook's (FB) Libra head David Marcus told a panel at the International Monetary Fund conference that he still expects to get 100 lenders and financial firms on board with the digital currency project once it addresses regulatory issues, Reuters' Michelle Price reports. "It will take time for us to address all of the regulatory concerns that were raised and it's our duty and our responsibility to come with answers to all of these questions," Marcus said. "I think once we've done this then I think we'll see more banks and traditional financial services firms join the effort." The news comes after several high-profile partners abandoned the project, including Visa (V), MasterCard (MA), PayPal (PYPL), Booking (BKNG), and eBay (EBAY). Reference Link

FB

Facebook

$188.81

(0.00%)

V

Visa

$177.55

-1.25 (-0.70%)

MA

MasterCard

$277.35

-1.29 (-0.46%)

PYPL

PayPal

$102.55

-0.99 (-0.96%)

BKNG

Booking Holdings

$2,026.75

9.12 (0.45%)

EBAY

eBay

$38.95

0.07 (0.18%)

  • 16

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 27

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

FB Facebook
$188.81

(0.00%)

10/15/19
RSBL
10/15/19
NO CHANGE
Target $242
RSBL
Buy
Rosenblatt a buyer of Facebook shares into Q3 report
Rosenblatt analyst Mark Zgutowicz is a buyer of Facebook shares into the company's Q3 results on Wednesday, October 30. Demand side indications remain strong for both News Feed and Instagram as respective return on ad spend remains at the top end of advertiser buys, Zgutowicz tells investors in a research note. However, with Facebook "under a regulator microscope," the analyst does not expect a "big" beat and raise quarter, but rather a modest beat and reduction to 2019 expense growth guidance. With the stock trading at 19 times estimated 2020 earnings, a modest beat will satisfy "the bar," contends Zgutowicz. He reiterates a Buy rating on Facebook with a $242 price target.
10/10/19
10/10/19
UPGRADE
Target $89

Outperform
Match Group upgraded to Outperform at Oppenheimer
As previously reported, Oppenheimer analyst Jason Helfstein upgraded Match Group (MTCH) to Outperform from Perform, with a price target of $89. The analyst notes that the stock is down 27% from its highs on an overall correction in momentum names, confusion surrounding a likely debt transfer as part ofthe spinoff from IAC (IAC) and concerns over the FTC lawsuit. Helfstein is now less concerned about competition from Facebook (FB) Dating, and highlights that 3P download data shows an acceleration in Tinder and localized offerings. Lastly, his survey work indicates that only 44% of U.S. singles are currently using an online dating product, suggesting material growth in overall usage.
10/15/19
JEFF
10/15/19
NO CHANGE
JEFF
Jefferies selective on Internet into Q3, most positive on Alphabet and Facebook
Jefferies analyst Brent Thill, who is "generally positive" on Internet sector fundamentals, tells investors to remain selective ahead of Q3 earnings. The analyst is most bullish on Alphabet (GOOGL), Facebook (FB), Expedia (EXPE), and Wix.com (WIX). He remains underweight TripAdvisor (TRIP), Shutterstock (SSTK), and Endurance (EIGI). Thill is most positive on Alphabet and Facebook. Alphabet's setup is better in the second half of the year relative to the first half due to easier comps, healthy core advertising, momentum in Google Cloud, and expanded hardware line-up ahead of the holidays, the analyst tells investors in a research note. He also likes Facebook's setup due to easier second half comps, recent product innovation on Instagram Commerce, and improvements to the core Facebook app. In e-commerce, Thill is a buyer of Amazon.com (AMZN) on any pullback. In travel, he like Expedia (EXPE) over Booking Holdings (BKNG). The analyst also views the recent selloff in Match Group (MTCH) shares as a buying opportunity.
10/16/19
BARD
10/16/19
NO CHANGE
Target $230
BARD
Outperform
Facebook checks generally positive but guidance could be overhang, says Baird
Baird analyst Colin Sebastian said Facebook will likely see upside to his and the Street's Q3 estimates as agency and advertiser checks suggest relatively steady growth rates versus the slowdown implied by guidance. The analyst believes the company's focus on privacy, data security, messaging , and other product improvements will continue to weigh on margins but he thinks it is likely embedded in investor expectations and consensus estimates. Sebastian reiterated his Outperform rating and $230 price target on Facebook shares.
V Visa
$177.55

-1.25 (-0.70%)

07/24/19
RAJA
07/24/19
NO CHANGE
Target $193
RAJA
Outperform
Visa price target raised to $193 from $177 at Raymond James
Raymond James analyst John Davis raised his price target for Visa to $193 from $177 following what he views as a "solid" Q3 print that included a top and bottom line beat, EPS guidance raise, and relatively stable quarter to date trends. The analyst reiterates an Outperform rating on the shares.
10/01/19
ADAM
10/01/19
NO CHANGE
Target $118
ADAM
Buy
PayPal payment processor deal beats card networks to China, says Canaccord
Canaccord analyst Joseph Vafi said Paypal's (PYPL) disclosure of its controlling stake in Chinese payment player GoPay has material strategic implications longer term. The analyst notes the deal allowed PayPal to beat both Visa (V) and Mastercard (MA) into the Chinese market and could be a conduit to drive meaningful cross-border payments volume allowing it to continue to sustain mid 20% payment volume for the next several years. Vafi reiterated his Buy rating and $118 price target on PayPal shares.
09/13/19
RHCO
09/13/19
NO CHANGE
Target $325
RHCO
Buy
MasterCard price target raised to $325 from $310 at SunTrust
SunTrust analyst Andrew Jeffrey raised his price target on MasterCard (MA) to $325 and kept his Buy rating, saying he expects the company to maintain its 10% or more EBITDA premium relative to Visa (V) and PayPal (PYPL). The analyst believes that MasterCard has a more durable organic revenue growth and offers a "differentiated competitive strategy" with its Real-Time Payments, adding that its monetization can be bolstered further by B2B products, cross-border payments, bill payments, point-of-sale technology, and other initiatives.
08/02/19
MSCO
08/02/19
NO CHANGE
Target $74
MSCO
Equal Weight
Square reported 'notable' deceleration in GPV, says Morgan Stanley
Morgan Stanley analyst James Faucette said the deceleration in gross payment volume, or GPV, growth reported by Square (SQ) this quarter was somewhat disappointing and "notable" given the strong U.S. consumer spending trends reported by other Payments players, including Visa (V) and MasterCard (MA). Combining this with the "deviation from Square's traditional beat-and-raise story" made him less positive about the report, although his calendar 2019 forecasts remain largely intact, said Faucette, who keeps an Equal Weight rating and $74 price target on Square shares.
MA MasterCard
$277.35

-1.29 (-0.46%)

09/16/19
MSCO
09/16/19
NO CHANGE
Target $315
MSCO
Overweight
MasterCard price target raised to $315 from $291 at Morgan Stanley
Morgan Stanley analyst James Faucette raised his price target on MasterCard shares to $315 from $291 following the company's Investment Community Meeting last week. The intra-quarter data shared by the company should ease some near-term macro concerns and the event left him feeling confident in "the key pillars" of his Overweight thesis, Faucette tells investors. MasterCard is also making notable progress on its longer term initiatives, which should support growth beyond the company's 3-year outlook, added Faucette.
PYPL PayPal
$102.55

-0.99 (-0.96%)

09/24/19
UBSW
09/24/19
NO CHANGE
Target $120
UBSW
Neutral
PayPal leads among P2P providers, app share remains stable, says UBS
UBS analyst Eric Wasserstrom is keeping his Neutral rating and $120 price target on PayPal as part of his broader research note into U.S. Payment Networks. The analyst states that his most recent UBS Evidence Lab Mobile Banking App Download data suggests that mobile payment apps continue to gain market share relative to the traditional banking apps, and within that category, remittance apps continue to lose share vs. P2P apps like Venmo. Wasserstrom adds that PayPal - while challenged by newer entrants like Square Cash - is still maintaining its leading position in P2P. The analyst maintains however that Venmo's contribution to PayPal's revenue and earnings is already reflected in the stock's premium multiple relative to its historical levels.
10/10/19
NOMU
10/10/19
NO CHANGE
Target $139
NOMU
Buy
PayPal likely to sign more Chinese partnerships, says Nomura Instinet
On the heels of PayPal's recent GoPay acquisition, more partnerships with Chinese mobile payments players may be in the works, Nomura Instinet analyst Bill Carcache tells investors in a research note. The analyst believes the GoPay deal has raised the possibility of more "mutually beneficial partnerships" between PayPal and key players inside China's payments ecosystem. He keeps a Buy rating on the shares with a $139 price target.
10/09/19
BTIG
10/09/19
NO CHANGE
Target $130
BTIG
Buy
BTIG lowers Q3 EPS view for PayPal after projected investment losses
BTIG analyst Mark Palmer lowers his Q3 EPS view on Paypal to 54c from 69c after the company disclosed an expected 15c impact in the quarter from unrealized losses in its strategic investment portfolio. The analyst is keeping his Buy rating and $130 price target on the stock however, citing the company's "differentiated assets" and "trusted brand" sustaining its leading position in digital payments.
BKNG Booking Holdings
$2,026.75

9.12 (0.45%)

09/26/19
WELS
09/26/19
DOWNGRADE
Target $2150
WELS
Market Perform
Booking Holdings downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Brian Fitzgerald downgraded Booking Holdings (BKNG) to Market Perform from Outperform and while raising his price target for the shares to $2,150 from $2,000. Changes to the online marketing environment for online travel agencies have eroded Booking's competitive advantage, Fitzgerald tells investors in a research note. Further, recent management changes the company's subsidiaries and product integration challenges suggest that Booking faces "significant hurdles" in achieving its vision of the "connected trip," adds the analyst. As such, Fitzgerald views the stock as fairly valued at current levels and does not believe it deserves a valuation premium relative to Expedia (EXPE).
09/26/19
WELS
09/26/19
DOWNGRADE
WELS
Market Perform
Booking Holdings downgraded to Market Perform from Outperform at Wells Fargo
09/27/19
09/27/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Box (BOX) downgraded to Underweight from Neutral at JPMorgan with analyst Mark Murphy saying while the stock has run higher, competition is intensifying in Box's target markets. 2. Atara Biotherapeutics (ATRA) downgraded to Sell from Neutral at Goldman Sachs with analyst Salveen Richter saying he sees a lack of near-term catalysts for the stock and questions surrounding the company's clinical programs. 3. Carnival (CCL) downgraded to Sell from Hold at Berenberg and to Neutral from Buy at UBS. 4. eBay (EBAY) and Booking Holdings (BKNG) downgraded to Market Perform from Outperform at Wells Fargo. 5. Canopy Growth (CGC) downgraded to Neutral from Buy at BofA/Merrill with analyst Christopher Carey saying while he still sees Canopy as a long-term leader in the cannabis industry, he thinks Canada industry growth is set to pause in the second half and potentially flatten, which he thinks could also be the case with Canopy. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
EBAY eBay
$38.95

0.07 (0.18%)

10/08/19
BARD
10/08/19
NO CHANGE
Target $46
BARD
Outperform
eBay tracker indicates Q3 volumes in-line with expectations, says Baird
Baird analyst Colin Sebastian said his eBay sales volume tracker for September indicates volumes are in-line with expectations; suggesting volume declines moderated sequentially during the quarter. The analyst expects internet sales tax collection will remain a near-term headwind but noted management conservatism has likely embedded the negative impact of these tax changes through the balance of the year. Sebastian maintained his Outperform rating and $46 price target on eBay shares.
09/26/19
WELS
09/26/19
DOWNGRADE
Target $45
WELS
Market Perform
eBay downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Brian Fitzgerald downgraded eBay to Market Perform from Outperform with an unchanged price target of $45. The company's slowing gross merchandise volume suggests stagnant or decreasing market share, Fitzgerald tells investors in a research note. Further, the analyst believes eBay's segment margins look lower than the activist investors are assuming in a breakup, which suggests to him "lower potential upside from the strategic review." Fitzgerald's sum-of-the-parts analysis lead him to believe that eBay shares are fairly valued. With that said, the company's 7.2% free cash flow and share buyback potentials limit downside risk on the stock, contends Fitzgerald.
09/26/19
WELS
09/26/19
DOWNGRADE
WELS
Market Perform
eBay downgraded to Market Perform from Outperform at Wells Fargo

TODAY'S FREE FLY STORIES

DSKE

Daseke

$2.62

-0.1 (-3.68%)

08:56
11/12/19
11/12
08:56
11/12/19
08:56
Earnings
Daseke reports Q3 EPS ($4.25), may not compare to consensus (16c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

GTT

GTT Communications

$8.47

0.32 (3.93%)

08:55
11/12/19
11/12
08:55
11/12/19
08:55
Hot Stocks
GTT expands scope of asset divestiture exploratory process »

GTT Communications said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 09

    Dec

AEP

American Electric

$88.78

-0.28 (-0.31%)

, AES

AES Corp.

$17.93

0.285 (1.62%)

08:55
11/12/19
11/12
08:55
11/12/19
08:55
Conference/Events
RBC Capital hosted company meetings at conference »

RBC Hosted Meetings at…

AEP

American Electric

$88.78

-0.28 (-0.31%)

AES

AES Corp.

$17.93

0.285 (1.62%)

A

Agilent

$76.82

0.19 (0.25%)

WK

Workiva

$41.35

0.68 (1.67%)

BKH

Black Hills

$74.73

-0.36 (-0.48%)

CMS

CMS Energy

$59.59

-0.01 (-0.02%)

CNP

CenterPoint Energy

$27.70

-1.08 (-3.75%)

D

Dominion

$79.62

-0.64 (-0.80%)

DUK

Duke Energy

$87.59

-2.35 (-2.61%)

ED

Consolidated Edison

$86.78

-0.385 (-0.44%)

EIX

Edison International

$66.35

-0.02 (-0.03%)

ETR

Entergy

$114.03

-0.94 (-0.82%)

EXC

Exelon

$44.02

-0.69 (-1.54%)

FE

FirstEnergy

$46.02

-0.575 (-1.23%)

NEE

NextEra Energy

$222.19

0.1 (0.05%)

PCG

PG&E

$6.24

-0.23 (-3.55%)

PEG

PSEG

$60.79

-0.66 (-1.07%)

PNM

PNM Resources

$47.47

-0.38 (-0.79%)

PNW

Pinnacle West

$85.17

-1.21 (-1.40%)

PPL

PPL Corp.

$33.62

-0.1 (-0.30%)

SO

Southern Company

$60.47

-0.78 (-1.27%)

SRE

Sempra Energy

$142.32

0.165 (0.12%)

WTR

Aqua America

$43.33

-0.24 (-0.55%)

XEL

Xcel Energy

$60.08

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 25

    Nov

  • 02

    Dec

  • 03

    Dec

  • 04

    Dec

  • 04

    Dec

  • 09

    Dec

  • 07

    Jan

RETA

Reata Pharmaceuticals

$213.52

1.48 (0.70%)

08:55
11/12/19
11/12
08:55
11/12/19
08:55
Recommendations
Reata Pharmaceuticals analyst commentary  »

Reata Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

AAPL

Apple

$262.16

1.96 (0.75%)

, GE

General Electric

$11.33

-0.185 (-1.61%)

08:55
11/12/19
11/12
08:55
11/12/19
08:55
Options
Notable open interest changes for November 12th »

Monday's total…

AAPL

Apple

$262.16

1.96 (0.75%)

GE

General Electric

$11.33

-0.185 (-1.61%)

TSLA

Tesla

$345.07

8.18 (2.43%)

SQ

Square

$63.75

1.265 (2.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 02

    Dec

  • 10

    Dec

  • 29

    Jan

  • 26

    Feb

ARE

Alexandria Real Estate

$155.11

1.19 (0.77%)

, AVB

AvalonBay

$210.53

0.74 (0.35%)

08:54
11/12/19
11/12
08:54
11/12/19
08:54
Conference/Events
RBC Capital hosted company meetings at conference »

RBC Hosted Company…

ARE

Alexandria Real Estate

$155.11

1.19 (0.77%)

AVB

AvalonBay

$210.53

0.74 (0.35%)

BXP

Boston Properties

$138.56

0.24 (0.17%)

CONE

CyrusOne

$65.36

-0.24 (-0.37%)

COR

CoreSite Realty

$113.84

0.22 (0.19%)

DLR

Digital Realty

$116.59

0.05 (0.04%)

DOC

Physicians Realty Trust

$18.20

0.08 (0.44%)

DRE

Duke Realty

$34.76

0.17 (0.49%)

EPR

EPR Properties

$73.03

-0.07 (-0.10%)

EQIX

Equinix

$534.44

4.28 (0.81%)

EQR

Equity Residential

$84.16

0.19 (0.23%)

ESS

Essex Property Trust

$313.80

-1.29 (-0.41%)

HR

Healthcare Realty Trust

$32.05

-0.145 (-0.45%)

HCP

HCP

$0.00

(0.00%)

VTR

Ventas

$59.10

-0.41 (-0.69%)

REG

Regency Centers

$64.83

0.17 (0.26%)

QTS

QTS Realty Trust

$50.99

0.3 (0.59%)

PLD

Prologis

$87.36

0.3 (0.34%)

INXN

Interxion

$81.78

0.885 (1.09%)

KIM

Kimco Realty

$20.89

0.05 (0.24%)

LMRK

Landmark Infrastructure

$15.50

-0.56 (-3.49%)

MAA

MAA

$132.85

-1.09 (-0.81%)

NNN

National Retail Properties

$55.56

0.38 (0.69%)

O

Realty Income

$76.53

0.22 (0.29%)

WELL

Welltower

$82.21

0.16 (0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 20

    Nov

  • 03

    Dec

  • 04

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 16

    Dec

  • 29

    Jan

BLPH

Bellerophon

$0.45

-0.0013 (-0.29%)

08:54
11/12/19
11/12
08:54
11/12/19
08:54
Hot Stocks
Bellerophon announces initial data from clinical study of INOpulse »

Bellerophon announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BREW

Craft Brew

$7.33

0.06 (0.83%)

08:53
11/12/19
11/12
08:53
11/12/19
08:53
Options
Little signs of information spillage in Craft Brew Alliance into deal »

Little signs of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

LLY

Eli Lilly

$112.78

-0.785 (-0.69%)

08:52
11/12/19
11/12
08:52
11/12/19
08:52
Hot Stocks
Lilly, Boehringer start sixth phase 3 study in Jardiance heart failure program »

Boehringer Ingelheim and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

08:52
11/12/19
11/12
08:52
11/12/19
08:52
Conference/Events
National Investment Banking Association to hold a conference »

NIBA 147th Investment…

APO

Apollo Global

$42.42

0.155 (0.37%)

08:51
11/12/19
11/12
08:51
11/12/19
08:51
Hot Stocks
Apollo Global appoints Joanna Rose as global head of corporate communications »

Apollo Global Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADC

Agree Realty

$74.27

-0.41 (-0.55%)

, AMH

American Homes 4 Rent

$25.84

0.14 (0.54%)

08:51
11/12/19
11/12
08:51
11/12/19
08:51
Conference/Events
Mizuho holds company meetings at conference »

Mizuho Company Meetings…

ADC

Agree Realty

$74.27

-0.41 (-0.55%)

AMH

American Homes 4 Rent

$25.84

0.14 (0.54%)

AVB

AvalonBay

$210.53

0.74 (0.35%)

BRX

Brixmor

$21.67

0.1 (0.46%)

BXP

Boston Properties

$138.56

0.24 (0.17%)

DOC

Physicians Realty Trust

$18.20

0.08 (0.44%)

EGP

EastGroup Properties

$130.66

-0.21 (-0.16%)

ESS

Essex Property Trust

$313.80

-1.29 (-0.41%)

FRT

Federal Realty

$131.34

-0.12 (-0.09%)

GLPI

Gaming and Leisure Properties

$42.52

0.51 (1.21%)

HCP

HCP

$0.00

(0.00%)

HIW

Highwoods Properties

$46.27

-0.2 (-0.43%)

KIM

Kimco Realty

$20.89

0.05 (0.24%)

LTC

LTC Properties

$46.67

0.29 (0.63%)

MAA

MAA

$132.85

-1.09 (-0.81%)

MHI

Morrison Mgmt Specialist

$12.07

-0.04 (-0.33%)

MPW

Medical Properties Trust

$19.91

-0.06 (-0.30%)

O

Realty Income

$76.53

0.22 (0.29%)

OFC

Corporate Office Properties

$29.15

-0.12 (-0.41%)

OHI

Omega Healthcare

$41.06

-0.02 (-0.05%)

STOR

Store Capital

$39.26

0.45 (1.16%)

TCO

Taubman Centers

$35.32

0.11 (0.31%)

TRNO

Terreno Realty

$55.51

-0.03 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 05

    Feb

  • 11

    Feb

IDCC

InterDigital

$57.53

-0.54 (-0.93%)

08:51
11/12/19
11/12
08:51
11/12/19
08:51
Conference/Events
InterDigital management to meet with Sidoti »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

VRTX

Vertex

$201.90

0.57 (0.28%)

08:51
11/12/19
11/12
08:51
11/12/19
08:51
Initiation
Vertex initiated  »

Vertex initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

CE

Celanese

$126.72

-0.58 (-0.46%)

, DD

DuPont

$72.18

1.04 (1.46%)

08:50
11/12/19
11/12
08:50
11/12/19
08:50
Recommendations
Celanese, DuPont analyst commentary  »

Celanese price targets…

CE

Celanese

$126.72

-0.58 (-0.46%)

DD

DuPont

$72.18

1.04 (1.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

UAVS

Ageagle Aerial Systems

$0.42

0.0385 (10.13%)

08:50
11/12/19
11/12
08:50
11/12/19
08:50
Hot Stocks
Ageagle's HempOverview solution selected by FDACS for registration process »

AgEagle Aerial Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

08:49
11/12/19
11/12
08:49
11/12/19
08:49
Conference/Events
Oppenheimer to hold a summit »

FinTech, Blockchain &…

CRUS

Cirrus Logic

$70.71

-0.44 (-0.62%)

08:49
11/12/19
11/12
08:49
11/12/19
08:49
Conference/Events
Cirrus Logic management to meet with Benchmark »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 21

    Nov

TPTX

Turning Point Therapeutics

$45.93

-1.07 (-2.28%)

08:49
11/12/19
11/12
08:49
11/12/19
08:49
Hot Stocks
Turning Point Therapeutics initiates Phase 1/2 clinical study of repotrectinib »

Turning Point…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:48
11/12/19
11/12
08:48
11/12/19
08:48
Conference/Events
UBS to hold a conference »

European Conference will…

CRTO

Criteo

$17.55

-0.27 (-1.52%)

08:48
11/12/19
11/12
08:48
11/12/19
08:48
Conference/Events
Criteo management to meet with DA Davidson »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 09

    Dec

EIGR

Eiger BioPharmaceuticals

$10.68

-0.41 (-3.70%)

08:48
11/12/19
11/12
08:48
11/12/19
08:48
Hot Stocks
Eiger announces presentation of results from Phase 2 LIFT Lambda study »

Eiger BioPharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RVVTF

Revive Therapeutics

$0.00

(0.00%)

08:47
11/12/19
11/12
08:47
11/12/19
08:47
Hot Stocks
Revive Therapeutics announces non-binding LOI to acquire Greeninsightz »

evive Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSCT

ForeScout

$32.52

1.57 (5.07%)

08:47
11/12/19
11/12
08:47
11/12/19
08:47
Recommendations
ForeScout analyst commentary  »

ForeScout may be valued…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 12

    Dec

ASUR

Asure Software

$9.20

0.01 (0.11%)

08:46
11/12/19
11/12
08:46
11/12/19
08:46
Recommendations
Asure Software analyst commentary  »

Asure Software price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.